ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
4Seasons
|
3.4K |
1.3M |
14 |
12/03/18 |
12/03/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Phase 2b CHF (LVAD) clinical trial
|
|
4Seasons
|
41 |
16K |
4 |
26/02/18 |
26/02/18 |
ASX - By Stock
|
41
|
16K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Receives RMAT For LVAD Heart Failure Patients
|
|
4Seasons
|
106 |
39K |
0 |
21/12/17 |
21/12/17 |
ASX - By Stock
|
106
|
39K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
4Seasons
|
840 |
220K |
10 |
01/12/17 |
01/12/17 |
ASX - By Stock
|
840
|
220K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
4Seasons
|
840 |
220K |
0 |
27/11/17 |
27/11/17 |
ASX - By Stock
|
840
|
220K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
4Seasons
|
840 |
220K |
17 |
25/11/17 |
25/11/17 |
ASX - By Stock
|
840
|
220K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
4Seasons
|
840 |
220K |
3 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
840
|
220K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
4Seasons
|
840 |
220K |
6 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
840
|
220K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
4Seasons
|
840 |
220K |
6 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
840
|
220K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell
|
|
4Seasons
|
278 |
62K |
2 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
278
|
62K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Back pain stem cell injection
|
|
4Seasons
|
136 |
40K |
1 |
09/11/17 |
09/11/17 |
ASX - By Stock
|
136
|
40K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Back pain stem cell injection
|
|
4Seasons
|
136 |
40K |
1 |
09/11/17 |
09/11/17 |
ASX - By Stock
|
136
|
40K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Back pain stem cell injection
|
|
4Seasons
|
136 |
40K |
2 |
07/11/17 |
07/11/17 |
ASX - By Stock
|
136
|
40K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
History of MSB's share issuance
|
|
4Seasons
|
38 |
11K |
5 |
06/11/17 |
06/11/17 |
ASX - By Stock
|
38
|
11K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
4Seasons
|
72 |
23K |
9 |
30/10/17 |
30/10/17 |
ASX - By Stock
|
72
|
23K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
29,000,000 Cross Trade Pre MArket
|
|
4Seasons
|
18 |
8.0K |
14 |
28/10/17 |
28/10/17 |
ASX - By Stock
|
18
|
8.0K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
6 |
16/10/17 |
16/10/17 |
ASX - By Stock
|
951
|
310K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
1 |
16/10/17 |
16/10/17 |
ASX - By Stock
|
951
|
310K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
7 |
13/10/17 |
13/10/17 |
ASX - By Stock
|
951
|
310K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
2 |
12/10/17 |
12/10/17 |
ASX - By Stock
|
951
|
310K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
4 |
12/10/17 |
12/10/17 |
ASX - By Stock
|
951
|
310K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
6 |
11/10/17 |
11/10/17 |
ASX - By Stock
|
951
|
310K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
4Seasons
|
951 |
310K |
1 |
11/10/17 |
11/10/17 |
ASX - By Stock
|
951
|
310K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Maxim Research - New York
|
|
4Seasons
|
32 |
10K |
17 |
27/09/17 |
27/09/17 |
ASX - By Stock
|
32
|
10K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
4Seasons
|
191 |
63K |
4 |
19/09/17 |
19/09/17 |
ASX - By Stock
|
191
|
63K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
4Seasons
|
191 |
63K |
5 |
13/09/17 |
13/09/17 |
ASX - By Stock
|
191
|
63K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Sell sell sell
|
|
4Seasons
|
30 |
11K |
4 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
30
|
11K
|
4
|
|
ASX - By Stock
|
MSB |
MSB in news
|
|
4Seasons
|
5 |
2.7K |
1 |
03/07/17 |
03/07/17 |
ASX - By Stock
|
5
|
2.7K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
4Seasons
|
8 |
4.4K |
3 |
15/06/17 |
15/06/17 |
ASX - By Stock
|
8
|
4.4K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
My thoughts on what matters to MNK
|
|
4Seasons
|
24 |
11K |
16 |
10/05/17 |
10/05/17 |
ASX - By Stock
|
24
|
11K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Dont understand
|
|
4Seasons
|
15 |
11K |
6 |
08/05/17 |
08/05/17 |
ASX - By Stock
|
15
|
11K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Japan as a Funding Source
|
|
4Seasons
|
13 |
6.8K |
3 |
29/04/17 |
29/04/17 |
ASX - By Stock
|
13
|
6.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
What happens when ...
|
|
4Seasons
|
65 |
30K |
7 |
26/04/17 |
26/04/17 |
ASX - By Stock
|
65
|
30K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
4Seasons
|
29 |
14K |
9 |
25/04/17 |
25/04/17 |
ASX - By Stock
|
29
|
14K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
invitation to madamanswer to comment
|
|
4Seasons
|
52 |
26K |
1 |
05/04/17 |
05/04/17 |
ASX - By Stock
|
52
|
26K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Morningstar $2.10 valuation
|
|
4Seasons
|
82 |
33K |
3 |
14/03/17 |
14/03/17 |
ASX - By Stock
|
82
|
33K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
If the science is false, why isn't it being challenged?
|
|
4Seasons
|
93 |
30K |
5 |
28/02/17 |
28/02/17 |
ASX - By Stock
|
93
|
30K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Two GREAT takeaways
|
|
4Seasons
|
34 |
13K |
18 |
19/02/17 |
19/02/17 |
ASX - By Stock
|
34
|
13K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Teva
|
|
4Seasons
|
39 |
8.1K |
3 |
15/02/17 |
15/02/17 |
ASX - By Stock
|
39
|
8.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Published Results Show MSB Cells Effective In RA Model
|
|
4Seasons
|
38 |
12K |
3 |
13/02/17 |
13/02/17 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mallinckrodt
|
|
4Seasons
|
35 |
10K |
3 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
35
|
10K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mallinckrodt
|
|
4Seasons
|
35 |
10K |
10 |
28/01/17 |
28/01/17 |
ASX - By Stock
|
35
|
10K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Mallinckrodt
|
|
4Seasons
|
35 |
10K |
11 |
28/01/17 |
28/01/17 |
ASX - By Stock
|
35
|
10K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Quarter Results On Form 6K
|
|
4Seasons
|
126 |
35K |
4 |
22/11/16 |
22/11/16 |
ASX - By Stock
|
126
|
35K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
RA Partner Discussions!
|
|
4Seasons
|
80 |
14K |
10 |
27/10/16 |
27/10/16 |
ASX - By Stock
|
80
|
14K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Japan Strategy Highlighted At Business Council Meeting-MSB.AX
|
|
4Seasons
|
58 |
13K |
5 |
13/10/16 |
13/10/16 |
ASX - By Stock
|
58
|
13K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Japan Strategy Highlighted At Business Council Meeting-MSB.AX
|
|
4Seasons
|
58 |
13K |
0 |
12/10/16 |
12/10/16 |
ASX - By Stock
|
58
|
13K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
4Seasons
|
141 |
31K |
5 |
15/09/16 |
15/09/16 |
ASX - By Stock
|
141
|
31K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Next 12 months
|
|
4Seasons
|
46 |
12K |
13 |
26/08/16 |
26/08/16 |
ASX - By Stock
|
46
|
12K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Dont wait till tommorrow
|
|
4Seasons
|
5 |
2.7K |
5 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
5
|
2.7K
|
5
|
|